MicroRNAs regulating signaling pathways in cardiac fibrosis: potential role of the exercise training

AC Improta-Caria, LF Rodrigues… - American Journal …, 2024 - journals.physiology.org
Cardiovascular and metabolic diseases such as hypertension, type 2 diabetes, and obesity
develop long-term fibrotic processes in the heart, promoting pathological cardiac …

Sympathetic overactivity, hypertension and cardiovascular disease: state of the art

G Grassi, LF Drager - Current Medical Research and Opinion, 2024 - Taylor & Francis
Cardiovascular disease (CVD) remains the most prevalent cause of premature death
worldwide. It had been suspected for decades that increased activity of the sympathetic …

[HTML][HTML] Dysregulated microRNAs in type 2 diabetes and breast cancer: Potential associated molecular mechanisms

AC Improta-Caria, F Ferrari, JLP Gomes… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Abstract Type 2 diabetes (T2D) is a multifaceted and heterogeneous syndrome associated
with complications such as hypertension, coronary artery disease, and notably, breast …

MicroRNAs (miRNAs) role in hypertension: pathogenesis and promising therapeutics

N Shaheen, A Shaheen, RA Diab… - Annals of Medicine and …, 2024 - journals.lww.com
Background: MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial
role in regulating various cellular processes, including cell proliferation, differentiation …

Overexpression of miR-126-5p in the serum of patients with systemic arterial hypertension is correlated with creatinine and platelets

AC Improta-Caria, CKV Nonaka, MG Aras, BA Nunes… - 2024 - researchsquare.com
Background: Systemic arterial hypertension is a multicausal and multifactorial disease of
high prevalence worldwide. The development, progression, and damage of target organs …